½ÃÀ庸°í¼­
»óǰÄÚµå
1808063

ÀÏȸ¿ë ÀÇ·á¿ëǰ ½ÃÀå : Á¦Ç° À¯Çü, ¼ÒÀç À¯Çü, ¸ê±Õ¼º, ¿ëµµ, ÃÖÁ¾»ç¿ëÀÚ, À¯Åë ä³Îº° - ¼¼°è ¿¹Ãø(2025-2030³â)

Disposable Medical Supplies Market by Product Type, Material Type, Sterility, Application, End User, Distribution Channel - Global Forecast 2025-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: 360iResearch | ÆäÀÌÁö Á¤º¸: ¿µ¹® 194 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

ÀÏȸ¿ë ÀÇ·á¿ëǰ ½ÃÀåÀº 2024³â¿¡´Â 3,920¾ï 9,000¸¸ ´Þ·¯¿¡ ´ÞÇϸç, 2025³â¿¡´Â 4,474¾ï 2,000¸¸ ´Þ·¯, CAGR 14.50%·Î ¼ºÀåÇϸç, 2030³â¿¡´Â 8,839¾ï 1,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

ÁÖ¿ä ½ÃÀå Åë°è
±âÁØ¿¬µµ 2024 3,920¾ï 9,000¸¸ ´Þ·¯
ÃßÁ¤¿¬µµ 2025 4,474¾ï 2,000¸¸ ´Þ·¯
¿¹Ãø¿¬µµ 2030 8,839¾ï 1,000¸¸ ´Þ·¯
CAGR(%) 14.50%

»õ·Î¿î µ¿Çâ, ±ÔÁ¦ ¿ªÇÐ, ½ÃÀå µ¿Çâ ¹× ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎÀÌ ÀÏȸ¿ë ÀÇ·á¿ëǰÀÇ ¹Ì·¡¸¦ °áÁ¤

ÀÏȸ¿ë ÀÇ·á¿ëǰÀº °¨¿°¿¡ ´ëÇÑ ÃÖÀü¹æ ¹æ¾î ¼ö´ÜÀÌÀÚ ÀÓ»ó ÇöÀåÀÇ È¿À²¼ºÀ» ³ôÀÌ´Â ±âÆøÁ¦·Î¼­ Çö´ë ÀÇ·á ¼­ºñ½º Á¦°ø¿¡ ¾ø¾î¼­´Â ¾È µÉ Çʼö ¿ä¼Ò·Î ÀÚ¸® Àâ¾Ò½À´Ï´Ù. ±âº»ÀûÀÎ ¼ö¼ú¿ë ¾×¼¼¼­¸®ºÎÅÍ Ã·´Ü Ä¡·á Áö¿ø Àåºñ¿¡ À̸£±â±îÁö ÀÌ·¯ÇÑ ÀÏȸ¿ëǰÀº ±³Â÷ ¿À¿°ÀÇ À§ÇèÀ» ÁÙÀ̸鼭 ȯÀÚ Ä¡·áÀÇ º£½ºÆ® ÇÁ·¢Æ¼½º¸¦ Áö¿øÇÕ´Ï´Ù. ÃÖ±Ù ÀÌ ºÐ¾ß´Â Á¦Ç° ¾ÈÀü Ç¥ÁØ¿¡ ´ëÇÑ °¨½Ã °­È­, ±ÔÁ¦ °¨µ¶ °­È­, ¼º´É ÀúÇÏ ¾øÀÌ È¯°æ¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» ÃÖ¼ÒÈ­ÇØ¾ß ÇÑ´Ù´Â ¾Ð·Â Áõ°¡¿¡ ´ëÀÀÇϰí ÀÖ½À´Ï´Ù.

Çõ½Å, Áö¼Ó°¡´ÉÇÑ °üÇà, ÁøÈ­ÇÏ´Â ±ÔÁ¦¿¡ ´ëÇÑ ±â´ë¸¦ ÅëÇØ ÀÏȸ¿ë ÀÇ·á¿ëǰÀ» ÀçÁ¤ÀÇÇÏ´Â º¯ÇõÀû º¯È­¸¦ Ç®¾î³À´Ï´Ù.

ÀÏȸ¿ë ÀÇ·á¿ëǰ »ê¾÷Àº Á¦Ç° °³¹ß, Á¦Á¶, ÀÓ»ó ȯ°æ¿¡¼­ÀÇ »ç¿ë ¹æ½ÄÀ» ÀçÁ¤ÀÇÇÏ´Â ´ëº¯ÇõÀ» °æÇèÇϰí ÀÖ½À´Ï´Ù. Àç·á °øÇÐÀÇ Çõ½ÅÀº À庮 ¼º´É°ú ȯ°æ ¹ßÀÚ±¹ °¨¼ÒÀÇ ±ÕÇüÀ» ¸ÂÃߴ ÷´Ü Æú¸®¸Ó¸¦ µµÀÔÇϰí, 3D ÇÁ¸°ÆÃ°ú °°Àº µðÁöÅÐ Á¦Á¶ ±â¼úÀº ÁÖ¹®Çü ¸ÂÃã ºÎǰÀÇ ÁÖ¹®Çü »ý»êÀÌ °¡´ÉÇÏ°Ô Çß½À´Ï´Ù. µ¿½Ã¿¡ ¼¾¼­¿Í ½º¸¶Æ® ÆÐŰ¡ ¼Ö·ç¼ÇÀÇ ÅëÇÕÀ¸·Î ÃßÀû¼ºÀ» °­È­ÇÏ¿© ÀÇ·á ¼­ºñ½º ÇÁ·Î¹ÙÀÌ´õ¿¡°Ô Àç°í °ü¸®¸¦ ÃÖÀûÈ­ÇÏ°í ¾ÈÀü Ç¥ÁØÀ» ÁؼöÇÒ ¼ö ÀÖ´Â ½Ç½Ã°£ µ¥ÀÌÅ͸¦ Á¦°øÇÏ¿© ¾ÈÀü Ç¥ÁØÀ» ÁؼöÇÒ ¼ö ÀÖµµ·Ï Áö¿øÇÕ´Ï´Ù.

2025³â ¹Ì±¹ °ü¼¼ º¯°æÀÌ ÀÇ·á¿ëǰ °ø±Þ¸Á, »ý»êºñ¿ë, ½ÃÀåÁøÀÔ¼º¿¡ ¹ÌÄ¡´Â ´©Àû ¿µÇâ °ËÅä

2025³â¿¡ ½ÃÇàµÉ ¹Ì±¹ÀÇ °ü¼¼ Á¶Á¤À» »ìÆìº¸¸é, ¼¼°è ÀÏȸ¿ë ÀÇ·á¿ëǰ ½ÃÀå¿¡ ¹ÌÄ¡´Â ±¤¹üÀ§ÇÑ ¿µÇâÀ» ¾Ë ¼ö ÀÖ½À´Ï´Ù. ´Ù¾çÇÑ ¼öÀÔ ºÎǰ ¹× ÇÃ¶ó½ºÆ½ ±â¹Ý ÀÏȸ¿ëǰ¿¡ ´ëÇÑ °ü¼¼¸¦ ÀλóÇÔÀ¸·Î½á »õ·Î¿î Á¶Ä¡´Â ºñ¿ë ±¸Á¶¸¦ À籸¼ºÇϰí Á¦Á¶¾÷ü°¡ °ø±Þ¸Á ±¸¼ºÀ» ÀçÆò°¡Çϵµ·Ï °­¿äÇß½À´Ï´Ù. ÇØ¿Ü »ý»ê¿¡ Å©°Ô ÀÇÁ¸ÇÏ´ø °ø±Þ¾÷üµéÀº ´Ï¾î¼î¾î¸µ ±¸»óÀ» °¡¼ÓÈ­ÇÏ°í ±¹³» Á¦Á¶¾÷ü¿ÍÀÇ Àü·«Àû ÆÄÆ®³Ê½ÊÀ» ±¸ÃàÇÏ¿© ¼öÀÔ °ü¼¼ ÀλóÀÇ ¿µÇâÀ» ¿ÏÈ­Çϰí ÀÖ½À´Ï´Ù.

Á¦Ç° À¯Çü, ¼ÒÀç À¯Çü, ¸ê±Õ¼º, ¿ëµµ, ÃÖÁ¾»ç¿ëÀÚ, À¯Åë ä³Î¿¡ °ÉÄ£ °¢ ¼¼ºÐÈ­¿¡ ´ëÇÑ ÀλçÀÌÆ®

Á¦Ç° À¯Çüº°·Î »ìÆìº¸¸é, ¼ö¼ú½Ç¿¡¼­´Â ¹è¾×°ü, ºñ¸ê±Õ µå·¹ÀÌÇÁ¿Í °°Àº ±âº»ÀûÀÎ ¼ö¼ú¿ë ¾×¼¼¼­¸®°¡ ±âº»ÀûÀÎ ¿ªÇÒÀ» ÇÏ´Â ¹Ý¸é, ¿Ü·¡ ȯÀÚ ¹× ÇöÀå Áø·á¿¡¼­´Â ½Ã·Â °Ë»çÇ¥, °Ëü ¿ë±â¿Í °°Àº Áø´Ü ¹× °Ë»ç ÅøÀÌ Á¡Á¡ ´õ Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖ½À´Ï´Ù. ¼Õ ¼Òµ¶Á¦ º´ºÎÅÍ ÀÇ·á Æó±â¹° ºÀÅõ¿¡ À̸£±â±îÁö °¨¿° °ü¸® ÇÁ·ÎÅäÄݰú Æó±â¹° °ü¸® ±ÔÁ¦°¡ °­È­µÊ¿¡ µû¶ó Æ÷Àå ¹× º¸°ü ¿ëǰÀÌ ´Ù½Ã ÇÑ ¹ø ÁÖ¸ñ¹Þ°í ÀÖ½À´Ï´Ù. ÇÑÆí, ÀçÅÃÄ¡·á ȯ°æ¿¡¼­ ħ´ë ÆÒ°ú ¼Òº¯ ÁָӴϸ¦ Æ÷ÇÔÇÑ È¯ÀÚ °ü¸® ¿ëǰ¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖÀ¸¸ç, °Ë»ç Àå°©¿¡¼­ ¼ö¼ú¿ë ĸ¿¡ À̸£±â±îÁö º¸È£ ¹× À§»ý¿ëǰÀº ¸ðµç ÀÓ»ó Á¢Á¡¿¡¼­ °è¼Ó ÇʼöÀûÀÔ´Ï´Ù. ¹Ù´Ã ¾ø´Â ÁÖ»ç±â, ÀÏȸ¿ë ¾àÄÅ µî Ä¡·á º¸Á¶±â±¸´Â ¸¸¼º±â ÀÇ·á Á¦°ø ¸ðµ¨°ú ÇÔ²² ÁøÈ­Çϰí ÀÖ½À´Ï´Ù.

ºÏ¹Ì, À¯·´, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«, ¾Æ½Ã¾ÆÅÂÆò¾ç ¿ªÇÐÀ» ºÐ¼®ÇÏ¿© ÀÇ·á ¿ëǰ Á¦Á¶¾÷üÀÇ ¼ºÀå ÆÐÅϰú ½ÃÀå ±âȸ¸¦ ¹àÈü´Ï´Ù.

ºÏ¹Ì¿Í ³²¹Ì¿¡¼­´Â ¼º¼÷ÇÑ ÀÇ·á ÀÎÇÁ¶ó°¡ È®¸³µÈ ±ÔÁ¦ ÇÁ·¹ÀÓ¿öÅ©¿¡ ÈûÀÔ¾î ÀÏȸ¿ë ÀÇ·á¿ëǰ¿¡ ´ëÇÑ ¾ÈÁ¤ÀûÀÎ ¼ö¿ä¸¦ Áö¼ÓÀûÀ¸·Î °ßÀÎÇϰí ÀÖ½À´Ï´Ù. ±¹³» Á¦Á¶ ´É·ÂÀº ÀÚµ¿È­ ¹× ÷´Ü Æú¸®¸Ó °¡°ø¿¡ ´ëÇÑ Àü·«Àû ÅõÀÚ¸¦ ÅëÇØ ¹«¿ª °ü·Ã ºñ¿ë º¯µ¿À» »ó¼âÇϱâ À§ÇÑ ³ë·ÂÀ» Áö¿øÇϰí ÀÖ½À´Ï´Ù. µ¿½Ã¿¡, ºÏ¹ÌÀÇ Áö¼Ó°¡´É¼º¿¡ ´ëÇÑ ³ë·ÂÀº ÀçȰ¿ë Àç·á ¹× ȸ¼ö ÇÁ·Î±×·¥À» ¸ð»öÇÏ´Â ½Ã¹ü ÇÁ·ÎÁ§Æ®¸¦ ÃËÁøÇϰí ÀÖÀ¸¸ç, ÀÌ´Â ÀÇ·á ¼­ºñ½º ÇÁ·Î¹ÙÀÌ´õÀÇ È¯°æ º¸È£¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁø °ÍÀ» ¹Ý¿µÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ ½ÃÀå ÁøÃâ±â¾÷Àº º¹ÀâÇÑ »óȯ ȯ°æ¿¡ ´ëÀÀÇϱâ À§ÇØ °¡Ä¡ ±â¹Ý Ä¡·á ¸ðµ¨°ú ºñ¿ë Àý°¨ ¿ì¼±¼øÀ§¿¡ µû¶ó Á¦Ç° Æ÷Æ®Æú¸®¿À¸¦ Á¶Á¤ÇØ¾ß ÇÏ´Â »óȲ¿¡ Á÷¸éÇØ ÀÖ½À´Ï´Ù.

ÀÏȸ¿ë ÀÇ·á¿ëǰÀÇ ÁÖ¿ä Á¦Á¶¾÷üÀÇ ÁÖ¿ä ³ë·Â°ú °æÀïÀû Æ÷Áö¼Å´×À» ¹àÈ÷°í, Çõ½ÅÀÇ ¸®´õ½Ê°ú ½ÃÀå¿¡ ¹ÌÄ¡´Â ¿µÇâ·ÂÀ» º¸¿©ÁÝ´Ï´Ù.

ÀÏȸ¿ë ÀÇ·á¿ëǰ ºÐ¾ßÀÇ ÁÖ¿ä ±â¾÷Àº ½ÃÀå¿¡¼­ÀÇ ÀÔÁö¸¦ °ø°íÈ÷ ÇÏ°í »õ·Î¿î ±âȸ¸¦ Æ÷ÂøÇϱâ À§ÇØ ´Ù°¢ÀûÀÎ Àü·«¿¡ Âø¼öÇϰí ÀÖ½À´Ï´Ù. ÀüÅë ÀÖ´Â Á¦Á¶¾÷üµéÀº ģȯ°æ ¼ÒÀç ¶óÀÎÀÇ µµÀÔ°ú ÃßÀû¼º ±â¼úÀ» Á¢¸ñÇÑ ½º¸¶Æ® ÆÐŰ¡ Æ÷Æ®Æú¸®¿ÀÀÇ È®ÀåÀ» ÅëÇØ Á¦Ç° Çõ½ÅÀ» ¿ì¼±½ÃÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ ¿¬±¸±â°ü ¹× º¥Ã³±â¾÷°úÀÇ Á¦ÈÞ¸¦ ÅëÇØ ÁøÈ­ÇÏ´Â ÀÓ»ó ¹× ȯ°æÀû ¿ä±¸»çÇ׿¡ ´ëÀÀÇÏ´Â Â÷¼¼´ë ÀÏȸ¿ë Á¦Ç°ÀÇ °³¹ß Áֱ⸦ ¾Õ´ç±â°í ÀÖ´Â °÷µµ ¸¹½À´Ï´Ù.

ÀÏȸ¿ë ÀÇ·á¿ëǰ ½ÃÀå¿¡¼­ÀÇ Çõ½Å ÃËÁø, °ø±Þ¸Á °­°Ç¼º °­È­, »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Ȱ¿ëÇϱâ À§ÇÑ ½ÇÇà °¡´ÉÇÑ Á¦¾È

¾÷°è ¸®´õµéÀº Á¦Ç° °³¹ß ÆÄÀÌÇÁ¶óÀο¡ Áö¼Ó°¡´ÉÇÑ ¼ÒÀç¿Í ¼øÈ¯ °æÁ¦ÀÇ ¿øÄ¢À» ¿ì¼±¼øÀ§¿¡ µÎ¾î¾ß ÇÕ´Ï´Ù. »ýºÐÇØ¼º Æú¸®¸Ó¿¡ ÅõÀÚÇÏ°í °ß°íÇÑ ÀçȰ¿ë ¹× ȸ¼ö ½Ã½ºÅÛÀ» ±¸ÃàÇÔÀ¸·Î½á ±â¾÷Àº ȯ°æ¿¡ ´ëÇÑ ±â´ëÄ¡°¡ ³ô¾ÆÁö´Â ȯ°æ¿¡ ´ëÀÀÇϰí Á¦Ç° Â÷º°È­¸¦ ²ÒÇÒ ¼ö ÀÖ½À´Ï´Ù. ±ÔÁ¦±â°ü°ú Á¶±â¿¡ Çù·ÂÇÏ¿© À¯¸®ÇÑ °¡À̵å¶óÀÎÀ» ¸¶·ÃÇÔÀ¸·Î½á ģȯ°æ ÀÏȸ¿ë ¼Ö·ç¼Ç ½ÃÀå ÁøÀÔÀ» ´õ¿í ÃËÁøÇÒ ¼ö ÀÖ½À´Ï´Ù.

1Â÷ Á¶»ç, 2Â÷ µ¥ÀÌÅÍ ºÐ¼®, Åë°èÀû °ËÁõÀ» ÅëÇÕÇÑ Á¶»ç ±â¹ýÀ¸·Î ½Å·Ú¼º°ú ½Ç¿ë¼ºÀÌ ³ôÀº ÀλçÀÌÆ®¸¦ Á¦°ø

ÀÌ Á¶»ç ¹æ¹ýÀº ½Å·ÚÇÒ ¼ö ÀÖ°í ½Ç¿ëÀûÀÎ ÀλçÀÌÆ®¸¦ ¾ò±â À§ÇØ °í¾ÈµÈ ¾ö°ÝÇÑ ¹æ¹ýÀ» Ȱ¿ëÇϰí ÀÖ½À´Ï´Ù. 1Â÷ µ¥ÀÌÅÍ ¼öÁýÀ» À§ÇØ ´Ù¾çÇÑ ÇコÄɾî ȯ°æÀÇ Á¶´Þ °ü¸®ÀÚ, ÀÓ»ó ¿£Áö´Ï¾î, ±ÔÁ¦ Àü¹®°¡, °ø±Þ¸Á Ã¥ÀÓÀÚ µî ÁÖ¿ä ÀÌÇØ°ü°èÀÚ¸¦ ´ë»óÀ¸·Î ±¸Á¶È­µÈ ÀÎÅͺ並 ½Ç½ÃÇß½À´Ï´Ù. ÀÌ·¯ÇÑ Á÷Á¢ÀûÀÎ °üÁ¡Àº ºñÁî´Ï½º °úÁ¦, ºñ¿ë ¿ä¼Ò, »õ·Î¿î Çõ½ÅÀÇ ¿ì¼±¼øÀ§¿¡ ´ëÇÑ Áß¿äÇÑ ¸Æ¶ôÀ» Á¦°øÇß½À´Ï´Ù.

ÀÏȸ¿ë ÀÇ·á¿ëǰ ºÐ¾ßÀÇ ¹Ì·¡ ¹æÇ⼺, Àü·«Àû Á߿伺 ¹× ¼ºÀå Àü¸Á¿¡ ´ëÇÑ Á¾ÇÕÀûÀÎ °á·ÐÀ» Á¦°øÇϱâ À§ÇÑ ÁÖ¿ä Á¶»ç °á°ú ÅëÇÕ

ÀÏȸ¿ë ÀÇ·á¿ëǰ ½ÃÀåÀº ±Þ¼ÓÇÑ ±â¼ú ¹ßÀü, ÁøÈ­ÇÏ´Â ±ÔÁ¦ »óȲ, Áö¼Ó°¡´É¼º¿¡ ´ëÇÑ ¿ä±¸°¡ ³ô¾ÆÁö´Â µî ¸Å¿ì Áß¿äÇÑ ±¹¸é¿¡ ³õ¿© ÀÖ½À´Ï´Ù. ½º¸¶Æ® ¼ÒÀçÀÇ Çõ½ÅÀûÀΠäÅÿ¡¼­ °ü¼¼ °³Çõ¿¡ µû¸¥ Àü·«Àû ÀçÆí¿¡ À̸£±â±îÁö ¾÷°è ÀÌÇØ°ü°èÀÚµéÀº °úÁ¦¿Í ±âȸ¿¡ ¶È°°ÀÌ Á÷¸éÇϰí ÀÖ½À´Ï´Ù. ¼¼ºÐÈ­ ºÐ¼®¿¡¼­´Â Á¦Ç°, ¼ÒÀç, ÃÖÁ¾»ç¿ëÀÚ, À¯Åë ä³Î¿¡ °ÉÄ£ ´Ù¾çÇÑ ´ÏÁ °­Á¶Çϰí, Áö¿ªº° ÀλçÀÌÆ®¿¡¼­´Â ¾Æ¸Þ¸®Ä«, À¯·´, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«, ¾Æ½Ã¾ÆÅÂÆò¾ç ½ÃÀå¿¡¼­ÀÇ °³º°Àû Á¢±ÙÀÇ Á߿伺À» °­Á¶ÇÕ´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå °³¿ä

Á¦4Àå ½ÃÀå °³¿ä

Á¦5Àå ½ÃÀå ¿ªÇÐ

Á¦6Àå ½ÃÀå ÀλçÀÌÆ®

  • Porter's Five Forces ºÐ¼®
  • PESTEL ºÐ¼®

Á¦7Àå ¹Ì±¹ °ü¼¼ÀÇ ´©Àû ¿µÇâ 2025

Á¦8Àå ÀÏȸ¿ë ÀÇ·á¿ëǰ ½ÃÀå : Á¦Ç° À¯Çüº°

  • ±âº»ÀûÀÎ ¼ö¼ú¿ë ¾×¼¼¼­¸®
    • ¹è¾× Æ©ºê
    • ºñ¸ê±Õ ¼ö¼ú¿ë µå·¹ÀÌÇÁ
    • Á¤Çü¿Ü°ú¿ë ¼¼¸é±â
  • Áø´Ü¡¤°Ë»ç Åø
    • ÇÃ¶ó½ºÆ½ ½Ã·Â °Ë»çÇ¥
    • ´ëº¯/»ýü °Ëü ¿ë±â
    • ¼³¾ÐÀÚ
    • ´¢»ùÇÃ ÄÅ
  • Æ÷À塤º¸°ü ¿ëǰ
    • ¼Õ¼Òµ¶¿ë º¸Æ²
    • ÀÇ·á Æó±â¹° ¹é
    • °ÅÁî/¸é¿ë ÇÃ¶ó½ºÆ½ Æ÷Àå
    • ÇÃ¶ó½ºÆ½ º¸Á¸ ¿ë±â
  • ȯÀÚ ÄÉ¾î ¿ëǰ
    • ÇÃ¶ó½ºÆ½ º£µåÆÒ
    • ä´¢ ¹é
    • ¹æ¼ö ħ´ë ÆÐµå
  • º¸È£¡¤À§»ý Àåºñ
    • °Ë»ç¿ë Àå°©
    • ÀÇ·á¿ë ÆäÀ̽º ¸¶½ºÅ©
    • ÇÃ¶ó½ºÆ½ ÀÏȸ¿ë ¿¡ÀÌÇÁ·±
    • Ŭ¸°·ë¿ë ½´Áî Ä¿¹ö
    • ¼ö¼ú¿ë ĸ
  • Ä¡·á Áö¿ø ±â±â
    • äÇ÷ »¡´ë
    • ÇÃ¶ó½ºÆ½ ÀÏȸ¿ë ¾àÄÅ
    • ±¸°­Ã»°áÁ¦ ÄÅ
    • ¹Ù´Ã ¾ø´Â ÁÖ»ç±â

Á¦9Àå ÀÏȸ¿ë ÀÇ·á¿ëǰ ½ÃÀå : ¼ÒÀç À¯Çüº°

  • ¶óÅØ½º
  • ±Ý¼Ó
  • ºÎÁ÷Æ÷
  • Á¾ÀÌ
  • ÇÃ¶ó½ºÆ½
  • °í¹«

Á¦10Àå ÀÏȸ¿ë ÀÇ·á¿ëǰ ½ÃÀå : ¸ê±Õ¼ºº°

  • ºñ¸ê±Õ
  • ¸ê±ÕÁ¦

Á¦11Àå ÀÏȸ¿ë ÀÇ·á¿ëǰ ½ÃÀå : ¿ëµµº°

  • ¸¶Ãë
  • ¾à¹°Àü´Þ
  • ¼ÒÈ­±â ³»°ú
  • ÀÏ¹Ý ¿Ü°ú
  • ºÎÀΰú
  • ¼Ò¾Æ°ú
  • ¼öÇ÷/Ç÷¾× °ü¸®
  • ºñ´¢±â°ú
  • â»ó °ü¸®

Á¦12Àå ÀÏȸ¿ë ÀÇ·á¿ëǰ ½ÃÀå : ÃÖÁ¾»ç¿ëÀÚº°

  • ¿Ü·¡ ¼ö¼ú ¼¾ÅÍ
  • Ŭ¸®´Ð
  • Áø´Ü °Ë»ç½Ç
  • ÀçÅà ÇコÄɾî
  • º´¿ø

Á¦13Àå ÀÏȸ¿ë ÀÇ·á¿ëǰ ½ÃÀå : À¯Åë ä³Îº°

  • ¿ÀÇÁ¶óÀÎ
  • ¿Â¶óÀÎ

Á¦14Àå ¾Æ¸Þ¸®Ä«ÀÇ ÀÏȸ¿ë ÀÇ·á¿ëǰ ½ÃÀå

  • ¹Ì±¹
  • ij³ª´Ù
  • ¸ß½ÃÄÚ
  • ºê¶óÁú
  • ¾Æ¸£ÇîÆ¼³ª

Á¦15Àå À¯·´, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ÀÏȸ¿ë ÀÇ·á¿ëǰ ½ÃÀå

  • ¿µ±¹
  • µ¶ÀÏ
  • ÇÁ¶û½º
  • ·¯½Ã¾Æ
  • ÀÌÅ»¸®¾Æ
  • ½ºÆäÀÎ
  • ¾Æ¶ø¿¡¹Ì¸®Æ®
  • »ç¿ìµð¾Æ¶óºñ¾Æ
  • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
  • µ§¸¶Å©
  • ³×´ú¶õµå
  • īŸ¸£
  • Çɶõµå
  • ½º¿þµ§
  • ³ªÀÌÁö¸®¾Æ
  • ÀÌÁýÆ®
  • Æ¢¸£Å°¿¹
  • À̽º¶ó¿¤
  • ³ë¸£¿þÀÌ
  • Æú¶õµå
  • ½ºÀ§½º

Á¦16Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ÀÏȸ¿ë ÀÇ·á¿ëǰ ½ÃÀå

  • Áß±¹
  • Àεµ
  • ÀϺ»
  • È£ÁÖ
  • Çѱ¹
  • Àεµ³×½Ã¾Æ
  • ű¹
  • Çʸ®ÇÉ
  • ¸»·¹À̽þÆ
  • ½Ì°¡Æ÷¸£
  • º£Æ®³²
  • ´ë¸¸

Á¦17Àå °æÀï ±¸µµ

  • ½ÃÀå Á¡À¯À² ºÐ¼®, 2024
  • FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º, 2024
  • °æÀï ºÐ¼®
    • 3M Company
    • Abbott Laboratories
    • B. Braun Melsungen AG
    • Becton, Dickinson and Company
    • Baxter International Inc.
    • Cardinal Health, Inc.
    • Gerresheimer AG
    • Lohmann & Rauscher GmbH & Co. KG
    • Halyard Health, Inc
    • Medline Industries, LP
    • Mercator Medical S.A.
    • Molnlycke Health Care AB
    • Nipro Corporation
    • PAUL HARTMANN AG
    • Samwoo Medical Co., Ltd.
    • SHENZHEN JUNYUAN MEDICAL EQUIPMENT CO., LTD.
    • Smith & Nephew plc
    • Stryker Corporation
    • Terumo Corporation
    • Vygon SAS.
    • SPM Medicare Pvt. Ltd
    • GWS Surgicals LLP
    • Narang Medical Limited.
    • Angiplast Pvt Ltd.

Á¦18Àå ¸®¼­Ä¡ AI

Á¦19Àå ¸®¼­Ä¡ Åë°è

Á¦20Àå ¸®¼­Ä¡ ÄÁÅÃ

Á¦21Àå ¸®¼­Ä¡ ±â»ç

Á¦22Àå ºÎ·Ï

KSA 25.09.25

The Disposable Medical Supplies Market was valued at USD 392.09 billion in 2024 and is projected to grow to USD 447.42 billion in 2025, with a CAGR of 14.50%, reaching USD 883.91 billion by 2030.

KEY MARKET STATISTICS
Base Year [2024] USD 392.09 billion
Estimated Year [2025] USD 447.42 billion
Forecast Year [2030] USD 883.91 billion
CAGR (%) 14.50%

Setting the Stage for the Future of Disposable Medical Supplies with Emerging Trends, Regulatory Dynamics, and Innovation Drivers Shaping Market Evolution

Disposable medical supplies have emerged as critical enablers of modern healthcare delivery, serving as frontline defenses against infection and catalysts for efficiency across clinical settings. From basic surgical accessories to advanced treatment support devices, these single-use items underpin best practices in patient care while mitigating cross-contamination risks. In recent years, the sector has navigated heightened scrutiny around product safety standards, intensified regulatory oversight, and mounting pressure to minimize environmental impact without compromising performance.

As healthcare providers confront evolving clinical protocols and cost containment targets, the disposable medical supply market has responded with innovations in materials science, production automation, and packaging design. Meanwhile, global events such as supply chain disruptions and shifting trade policies have underscored the need for greater agility in sourcing and distribution. Sustainability considerations have further driven exploration of biodegradable polymers and reprocessing initiatives to reduce plastic waste footprints.

This executive summary offers a concise yet comprehensive overview of industry dynamics that are reshaping disposable medical supplies. It examines the transformative shifts in technology and regulation, the cumulative impact of recent tariff developments, and the nuanced segmentation that defines product, material, sterility, application, end user, and distribution channel landscapes. In addition, regional trends, competitive strategies, actionable recommendations for industry leaders, and methodological rigor are outlined to equip decision makers with strategic insights for navigating future challenges and opportunities in this vital market segment.

Unveiling Transformative Shifts Redefining Disposable Medical Supplies Through Innovation, Sustainable Practices, and Evolving Regulatory Expectations

The disposable medical supplies sector has experienced sweeping transformative shifts that are redefining how products are developed, manufactured, and utilized within clinical environments. Innovations in materials engineering have introduced advanced polymers that balance barrier performance with reduced environmental footprints, while digital fabrication techniques such as 3D printing enable on-demand production of custom-fit components. Simultaneously, the integration of sensors and smart packaging solutions is enhancing traceability, providing healthcare providers with real-time data to optimize inventory management and ensure compliance with safety standards.

Moreover, sustainable practices have moved from aspirational goals to operational imperatives, driving investment in biodegradable alternatives and closed-loop recycling initiatives. In parallel, patient-centric design principles have gained prominence, leading to ergonomic packaging formats and intuitive labeling that support the growing trend toward outpatient and home-based care. These developments have been further accelerated by telehealth adoption, which has introduced novel supply requirements and challenged manufacturers to deliver user-friendly disposables that uphold clinical efficacy outside of traditional facilities.

In addition, evolving regulatory expectations are shaping product lifecycles through stricter quality assessments, environmental reporting mandates, and updated guidelines for single-use devices. Coupled with ongoing supply chain recalibrations in response to global disruptions, industry stakeholders are now navigating an increasingly complex landscape. These transformative pillars set the foundation for a deeper exploration of how trade policies, segmentation insights, and regional dynamics will further influence strategic decision making across the disposable medical supplies market.

Examining the Cumulative Impact of United States Tariff Changes in 2025 on Supply Chains, Production Costs, and Market Accessibility for Medical Supplies

Examining the United States' tariff adjustments implemented in 2025 reveals extensive implications for the global disposable medical supplies market. By raising duties on a range of imported components and plastic-based disposables, new measures have reshaped cost structures and compelled manufacturers to reevaluate supply chain configurations. Suppliers that once relied heavily on overseas production have accelerated nearshoring initiatives and forged strategic partnerships with domestic fabricators to mitigate exposure to elevated import levies.

The ripple effects extend to procurement negotiations within healthcare institutions, where administrators now factor tariff-induced price differentials into purchasing decisions and long-term contracts. At the same time, manufacturers are exploring alternative materials and processing technologies that can deliver equivalent performance at more competitive cost points. This shift has fostered innovation in polymer chemistry and spurred pilot programs aimed at optimizing material utilization to offset duty burdens.

Furthermore, the adjustments have highlighted the importance of flexible logistics networks, prompting investment in multi-modal transport solutions and regional distribution hubs that can circumvent tariff barriers. As stakeholders adapt to these evolving trade dynamics, they are also engaging in dialogue with policymakers to articulate the economic and public health implications of protective measures. Ultimately, the 2025 tariff landscape underscores the critical need for agility, collaboration, and creative resource management to sustain supply continuity and uphold affordability in the disposable medical supplies sector.

Segmentation Insights Across Product Lines, Materials, Sterility Levels, Applications, End Users, and Channels Shaping Tomorrow's Market Trajectory

A nuanced view of the product type landscape reveals that basic surgical accessories encompassing items such as drainage tubes and non-sterile drapes maintain foundational roles in the operating room, while diagnostic and examination tools like visual acuity charts and specimen containers play an increasingly critical role in outpatient and point-of-care settings. Packaging and storage supplies, from hand sanitizer bottles to medical waste bags, have gained renewed attention due to enhanced infection control protocols and waste management regulations. Meanwhile, patient care items that include bedpans and urine collection bags are encountering heightened demand in home healthcare environments, and protective and hygiene equipment ranging from examination gloves to surgical caps remain indispensable across all clinical touchpoints. Treatment support devices such as syringes without needles and disposable medicine cups continue to evolve in tandem with chronic care delivery models.

From a material perspective, the market has witnessed a gradual shift toward nonwoven fabrics and engineered plastics that offer superior barrier properties while supporting lightweight, cost-effective production. Traditional materials such as latex and rubber still underpin critical components but are adapting through thin-film technologies and hybrid constructs that optimize performance. Metal-based single-use instruments, although representing a smaller segment by volume, command premium pricing owing to stringent quality requirements and sterilization standards.

Sterility considerations delineate clear stratifications between sterile disposables used in invasive procedures and non-sterile items suitable for general applications, with both categories subject to rigorous regulatory controls. Application-specific dynamics underscore strong deployment in general surgery and drug delivery contexts, while specialized domains such as transfusion management and wound care are emerging as high-growth niches driven by advancing therapeutic modalities. End user segmentation highlights hospitals as the principal consumption hub, yet ambulatory surgical centers and home healthcare providers are rapidly expanding their share of procurements. Finally, the distribution channel continuum reflects a predominantly offline model, even as online procurement portals gain traction by offering streamlined ordering and faster replenishment cycles.

Assessing Regional Dynamics in the Americas, EMEA, and Asia-Pacific to Illuminate Growth Patterns and Market Opportunities for Medical Supply Providers

In the Americas, a mature healthcare infrastructure underpinned by well-established regulatory frameworks continues to drive consistent demand for disposable medical supplies. Domestic manufacturing capabilities have benefited from strategic investments in automation and advanced polymer processing, supporting efforts to offset trade-related cost fluctuations. Concurrently, sustainability initiatives in North America have catalyzed pilot projects exploring recycled materials and take-back programs, reflecting growing environmental stewardship among providers. Market participants are also navigating complex reimbursement environments, prompting them to align product portfolios with value-based care models and cost containment priorities.

Within Europe, the Middle East, and Africa region, stringent directives on single-use plastics and robust environmental regulations have spurred innovation in biodegradable and compostable alternatives. Western European markets exhibit strong adoption of eco-oriented disposables, while emerging healthcare systems in the Middle East and Africa are investing in capacity expansions that heighten overall volume growth. Across this diverse landscape, digital health integration and e-procurement platforms are enabling more efficient supply chain orchestration, even as logistical challenges persist in remote and underserved areas.

The Asia-Pacific region stands out for its combination of rapidly expanding healthcare access and competitive manufacturing ecosystems. Governments across the region are channeling funds into facility upgrades and universal coverage schemes that amplify demand for single-use items. At the same time, low-cost production hubs in countries such as China and India continue to attract external partnerships, driving export activity despite intermittent trade tensions. Taken together, these regional dynamics underscore the importance of localized strategies that address regulatory nuances, supply chain resilience, and evolving provider requirements.

Revealing Key Initiatives and Competitive Positioning of Leading Disposable Medical Supply Manufacturers to Showcase Innovation Leadership and Market Impact

Leading players in the disposable medical supply sector have embarked on multifaceted strategies to solidify their market positions and capture emerging opportunities. Established manufacturers are prioritizing product innovation through the introduction of eco-friendly material lines and the expansion of smart packaging portfolios that incorporate traceability technologies. In addition, many are pursuing collaborative partnerships with research institutions and start-up ventures to accelerate development cycles for next-generation disposables that align with evolving clinical and environmental requirements.

Mergers and acquisitions have also featured prominently, enabling companies to broaden their geographical reach and augment capabilities in specialized segments such as wound management and drug delivery systems. These transactions frequently emphasize the integration of advanced manufacturing processes and digital solutions that streamline quality control, regulatory compliance, and customer engagement. At the same time, strategic investments in regional distribution networks are helping industry champions to enhance responsiveness and reduce lead times for critical items.

Meanwhile, smaller, niche-focused organizations are carving out competitive niches by targeting underrepresented applications and delivering tailored service models to ambulatory centers and home healthcare providers. Their agility in responding to specific customer needs has catalyzed pilot programs aimed at validating novel materials and customized packaging formats. Overall, these strategic approaches are redefining how companies engage with healthcare providers and adapt to shifting market demands, underscoring the importance of continuous evolution to maintain competitive advantage in a dynamic industry.

Actionable Recommendations to Drive Innovation, Strengthen Supply Chain Resilience, and Capitalize on Emerging Opportunities in the Disposable Medical Supplies Market

Industry leaders should prioritize the integration of sustainable materials and circular economy principles into product development pipelines. By investing in biodegradable polymers and establishing robust recycling or take-back schemes, companies can address rising environmental expectations and differentiate their offerings. Early collaboration with regulatory bodies to shape favorable guidelines will further facilitate market entry for eco-conscious disposable solutions.

To enhance supply chain resilience, organizations are encouraged to diversify sourcing strategies by incorporating nearshore and regional production capabilities. Developing multi-modal logistics partnerships and maintaining buffer inventories for critical components can mitigate the impact of future trade disruptions or raw material shortages. Cultivating transparent relationships with suppliers and leveraging collaborative forecasting models will also improve responsiveness and cost control.

Embracing digital transformation across manufacturing and distribution operations is essential for maintaining competitive advantage. Deploying IoT-enabled sensors, blockchain-based traceability systems, and advanced data analytics tools will unlock real-time visibility into inventory levels, product quality, and demand trends. These digital investments not only streamline compliance but also foster predictive maintenance and more agile replenishment cycles.

Finally, companies should refine their product portfolios through rigorous segmentation analysis and customer feedback loops to align with evolving clinical requirements. By adopting consultative service models for hospitals, clinics, and home healthcare providers, manufacturers can deepen strategic partnerships and co-create value-added solutions. Implementing cross-functional innovation teams that bring together R&D, regulatory affairs, and commercial experts will accelerate the development of differentiated disposable medical supplies designed for tomorrow's healthcare landscape.

Outlining Research Methodology Integrating Primary Interviews, Secondary Data Analysis, and Statistical Validation to Deliver Reliable and Actionable Insights

This research leverages a rigorous methodology designed to yield reliable and actionable insights. Primary data collection involved structured interviews with key stakeholders, including procurement managers, clinical engineers, regulatory experts, and supply chain directors across diverse healthcare settings. These firsthand perspectives provided critical context on operational challenges, cost drivers, and emerging innovation priorities.

Complementing primary research, an extensive secondary analysis was conducted, examining publicly available documents such as regulatory filings, patent records, company white papers, and peer-reviewed journals. This multifaceted approach enabled the synthesis of historical trends, technological advancements, and policy developments. Data triangulation techniques were applied to reconcile discrepancies between sources and to validate core findings.

In addition, regional case studies and comparative assessments were employed to illuminate jurisdiction-specific dynamics and cross-regional patterns. A dedicated review panel of industry veterans and academic specialists rigorously evaluated the research outputs, ensuring that analytical frameworks and conclusions adhered to the highest standards of academic integrity and commercial relevance. Throughout the process, iterative feedback cycles refined data interpretation, and transparency measures-such as documented assumptions and methodological appendices-were implemented to support reproducibility and confidence in the results.

Synthesizing Key Findings to Provide a Cohesive Conclusion on Future Directions, Strategic Imperatives, and Growth Prospects in the Disposable Medical Supplies Domain

The disposable medical supplies market stands at a pivotal moment characterized by rapid technological advancements, evolving regulatory landscapes, and growing sustainability imperatives. From the transformative adoption of smart materials to the strategic realignments prompted by tariff reforms, industry stakeholders face both challenges and opportunities in equal measure. Segmentation analysis has highlighted the diverse needs across product categories, materials, end users, and distribution channels, while regional insights underscore the importance of tailored approaches in the Americas, EMEA, and Asia-Pacific markets.

Competitive intelligence reveals that success will hinge on a balanced pursuit of scale and innovation, as leading manufacturers and agile niche players alike navigate an environment defined by cost pressures, quality demands, and environmental accountability. Actionable recommendations emphasize the adoption of circular economy principles, supply chain diversification, and digital integration to build resilience and unlock new growth pathways.

In closing, organizations that align strategic investments with emerging client priorities and regulatory trends will be best positioned to deliver high-impact disposable medical supply solutions. By leveraging rigorous research methodologies and fostering cross-sector collaboration, companies can chart a sustainable, forward-looking course in this dynamic sector. The insights presented here form a strategic roadmap for decision makers seeking to drive innovation, enhance operational efficiency, and achieve long-term market differentiation.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Market Sizing & Forecasting

5. Market Dynamics

  • 5.1. Rising adoption of eco-friendly biodegradable medical gloves to reduce plastic waste
  • 5.2. Integration of antimicrobial coatings in single-use catheters to prevent hospital infections
  • 5.3. Surge in demand for prefilled syringes driven by expanding vaccination programs
  • 5.4. Increasing use of smart wound dressings with sensors for real-time patient monitoring
  • 5.5. Rapid growth of single-use endoscopes to minimize cross-contamination risks in hospitals
  • 5.6. Expansion of personalized disposable surgical kits tailored for outpatient procedure efficiency
  • 5.7. Regulatory push for enhanced sterilization standards accelerating innovation in disposable medical devices
  • 5.8. Biodegradable polymer innovation reshaping disposable medical product sustainability
  • 5.9. Surge in smart sensor integration accelerating remote patient monitoring disposables
  • 5.10. Regulatory tightening on sterilization protocols driving single use device redesign

6. Market Insights

  • 6.1. Porter's Five Forces Analysis
  • 6.2. PESTLE Analysis

7. Cumulative Impact of United States Tariffs 2025

8. Disposable Medical Supplies Market, by Product Type

  • 8.1. Introduction
  • 8.2. Basic Surgical Accessories
    • 8.2.1. Drainage Tubes
    • 8.2.2. Non-Sterile Surgical Drapes
    • 8.2.3. Plastic Surgical Basins
  • 8.3. Diagnostic & Examination Tools
    • 8.3.1. Plastic Visual Acuity Charts
    • 8.3.2. Stool/Biological Specimen Containers
    • 8.3.3. Tongue Depressors
    • 8.3.4. Urine Sample Cups
  • 8.4. Packaging & Storage Supplies
    • 8.4.1. Hand Sanitizer Plastic Bottles
    • 8.4.2. Medical Waste Bags
    • 8.4.3. Plastic Packaging for Gauze/Cotton
    • 8.4.4. Plastic Storage Containers
  • 8.5. Patient Care Items
    • 8.5.1. Plastic Bedpans
    • 8.5.2. Urine Collection Bags
    • 8.5.3. Waterproof Bed Pads
  • 8.6. Protective & Hygiene Equipment
    • 8.6.1. Examination Gloves
    • 8.6.2. Medical Face Masks
    • 8.6.3. Plastic Disposable Aprons
    • 8.6.4. Shoe Covers for Cleanrooms
    • 8.6.5. Surgical Caps
  • 8.7. Treatment Support Devices
    • 8.7.1. Blood Collection Straws
    • 8.7.2. Disposable Plastic Medicine Cups
    • 8.7.3. Mouthwash Cups
    • 8.7.4. Syringes without Needles

9. Disposable Medical Supplies Market, by Material Type

  • 9.1. Introduction
  • 9.2. Latex
  • 9.3. Metal
  • 9.4. Nonwoven Fabric
  • 9.5. Paper
  • 9.6. Plastic
  • 9.7. Rubber

10. Disposable Medical Supplies Market, by Sterility

  • 10.1. Introduction
  • 10.2. Non Sterile
  • 10.3. Sterile

11. Disposable Medical Supplies Market, by Application

  • 11.1. Introduction
  • 11.2. Anaesthesia
  • 11.3. Drug Delivery
  • 11.4. Gastroenterology
  • 11.5. General Surgery
  • 11.6. Gynaecology
  • 11.7. Paediatric
  • 11.8. Transfusion/Blood Management
  • 11.9. Urology
  • 11.10. Wound Management

12. Disposable Medical Supplies Market, by End User

  • 12.1. Introduction
  • 12.2. Ambulatory Surgical Centers
  • 12.3. Clinics
  • 12.4. Diagnostic Laboratories
  • 12.5. Home Healthcare
  • 12.6. Hospitals

13. Disposable Medical Supplies Market, by Distribution Channel

  • 13.1. Introduction
  • 13.2. Offline
  • 13.3. Online

14. Americas Disposable Medical Supplies Market

  • 14.1. Introduction
  • 14.2. United States
  • 14.3. Canada
  • 14.4. Mexico
  • 14.5. Brazil
  • 14.6. Argentina

15. Europe, Middle East & Africa Disposable Medical Supplies Market

  • 15.1. Introduction
  • 15.2. United Kingdom
  • 15.3. Germany
  • 15.4. France
  • 15.5. Russia
  • 15.6. Italy
  • 15.7. Spain
  • 15.8. United Arab Emirates
  • 15.9. Saudi Arabia
  • 15.10. South Africa
  • 15.11. Denmark
  • 15.12. Netherlands
  • 15.13. Qatar
  • 15.14. Finland
  • 15.15. Sweden
  • 15.16. Nigeria
  • 15.17. Egypt
  • 15.18. Turkey
  • 15.19. Israel
  • 15.20. Norway
  • 15.21. Poland
  • 15.22. Switzerland

16. Asia-Pacific Disposable Medical Supplies Market

  • 16.1. Introduction
  • 16.2. China
  • 16.3. India
  • 16.4. Japan
  • 16.5. Australia
  • 16.6. South Korea
  • 16.7. Indonesia
  • 16.8. Thailand
  • 16.9. Philippines
  • 16.10. Malaysia
  • 16.11. Singapore
  • 16.12. Vietnam
  • 16.13. Taiwan

17. Competitive Landscape

  • 17.1. Market Share Analysis, 2024
  • 17.2. FPNV Positioning Matrix, 2024
  • 17.3. Competitive Analysis
    • 17.3.1. 3M Company
    • 17.3.2. Abbott Laboratories
    • 17.3.3. B. Braun Melsungen AG
    • 17.3.4. Becton, Dickinson and Company
    • 17.3.5. Baxter International Inc.
    • 17.3.6. Cardinal Health, Inc.
    • 17.3.7. Gerresheimer AG
    • 17.3.8. Lohmann & Rauscher GmbH & Co. KG
    • 17.3.9. Halyard Health, Inc
    • 17.3.10. Medline Industries, LP
    • 17.3.11. Mercator Medical S.A.
    • 17.3.12. Molnlycke Health Care AB
    • 17.3.13. Nipro Corporation
    • 17.3.14. PAUL HARTMANN AG
    • 17.3.15. Samwoo Medical Co., Ltd.
    • 17.3.16. SHENZHEN JUNYUAN MEDICAL EQUIPMENT CO., LTD.
    • 17.3.17. Smith & Nephew plc
    • 17.3.18. Stryker Corporation
    • 17.3.19. Terumo Corporation
    • 17.3.20. Vygon SAS.
    • 17.3.21. SPM Medicare Pvt. Ltd
    • 17.3.22. GWS Surgicals LLP
    • 17.3.23. Narang Medical Limited.
    • 17.3.24. Angiplast Pvt Ltd.

18. ResearchAI

19. ResearchStatistics

20. ResearchContacts

21. ResearchArticles

22. Appendix

»ùÇà ¿äû ¸ñ·Ï
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
¸ñ·Ï º¸±â
Àüü»èÁ¦